Visit our Booth #8025 at AAPM 2017
Virtual Phantoms will be exhibiting at the American Association of Physicists in Medicine (AAPM) annual meeting in Denver, CO – July 30 – August 3, 2017. Find us in Booth #8025 Dr. Peter Caracappa, Chief Technology Officer, and John Crossin, Chief Operating Officer, will be there to show our products and answer your questions. If you would like to schedule an appointment ahead of time, email peter.caracappa@virtualphantoms.com to set up a time. See you in...
read moreFollow Virtual Phantoms on Facebook, Twitter, LinkedIn
Keep track of the news from Virtual Phantoms through your favorite social media sites! We have established a presence on Facebook, Twitter, and LinkedIn — follow us with the links below: Facebook: Twitter: Follow @VPI_VirtualDose ...
read moreMedsquare signs a partnership with Virtual Phantoms to add a new module: calculation of the organ dose
February 28, 2017 — Medsquare is proud to announce the integration of the organ dose module ‘VirtualDose™CT’ into its DACS Radiation Dose Monitor (RDM) solution. Developed in partnership with Virtual Phantoms, Inc., this new module will be added to RDM’s existing features and will be presented for the first time at the European Congress of Radiology (ECR). The features of the organ dose module are the following: Monte Carlo algorithm calculation of mean doses delivered to organs by type of activity using existing dose data (DLP, CTDI, etc.) Estimation of the dose received by the fetus from the different stages of gestation of the pregnant woman Several parameters are considered: weight, height, age, pregnancy stages of the pregnant woman, etc. Calculation in accordance with ICRP- 60 and ICRP-103 recommendations “With the calculation of the organ dose, Medsquare is opening a new perspective on patient radiation safety. This agreement − the fruit of over several months of exchanges between the two companies − continues the process of reducing and optimizing the dose delivered to the patient,” said Dominique Gabriel, CEO Medsquare. *DACS: Dose Arching and Communication System About Virtual Phantoms Inc Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF in the field of nuclear and radiological engineering. Combining a large collection of anatomically accurate models of patients of various ages and sizes and sophisticated “Monte Carlo” simulation methods originally developed for nuclear weapons research at Los Alamos in the 1940s, VPI is recognized as a world leader in the modeling of ionizing radiation, radiation safety, and medical/occupational radiation dosimetry. For more information about Virtual Phantoms or VirtualDose™CT: Website: www.virtualphantoms.com Contact: Peter Caracappa, VPI Chief Technology Officer; +1 518-421 6931, peter.caracappa@virtualphantoms.com. About Medsquare Medsquare provides innovative solutions for the medical imaging environment. Our solutions (burning, printing, archiving, secured web image distribution through the internet, etc.) are currently being used in more than 450 university hospitals and private clinics in France and more than 2000 around the world. Founded in 2006 as a French company based in Paris, Medsquare is a key partner of the world’s leading radiology equipment manufacturers, who offer our peripheral devices and software to their customers bundled with the sale of their DICOM modalities (CT, MR, XA, etc.). Medsquare is also a leading player in the DACS (Dose Archiving and Communication System) market. Our patient dose management system – Radiation Dose Monitor (RDM) – enables healthcare institutions to collect, control and analyze radiation doses delivered to patients during medical imaging exams. RDM helps improve clinical practices and optimize doses. Contact Karen FRANGIE: k.frangie@medsquare.com Communication Leader Medsquare 17 rue du Jura 75013, Paris – France T: + 33 (0)1 55 25 62 50 For more information, visit our website: www.medsquare.com *DACS: Dose Arching and Communication System PDF Press Release PDF Press Release...
read moreQAELUM Announces Partnership with Virtual Phantoms, Inc to Add Organ Dose Data to Radiation Dose Monitoring Software
QAELUM Announces Partnership with Virtual Phantoms, Inc to Add Organ Dose Data to Radiation Dose Monitoring Software (12th January 2017) — Qaelum NV, of Heverlee, Belgium, and Virtual Phantoms, Inc of Albany, NY USA announced today that they have entered into a partnership to bring the VirtualDose™CT organ dose tool to the Qaelum radiation dose monitoring solution, DOSE. With this partnership, Qaelum further optimizes their software solutions dedicated to patient safety and efficiency in medical imaging. Patient safety in medical imaging is a priority With increasing awareness of the risk of radiation dose, patient safety is a high priority in medical imaging departments. Radiation dose during medical examination can be optimized and monitored by DOSE, one of the total quality monitoring solutions of Qaelum, a KULeuven spinoff. As the different organs of a human body are of variable dimensions and variable tissue composition, specifying organ radiation dose requires models that take all these variables into account. “We are pleased to announce that advanced organ-dose calculation functionality is now available in DOSE, thanks to partnership with VirtualDoseCT and Virtual Phantoms, Inc.,” said Jurgen Jacobs, CEO of Qaelum NV. “The inclusion of organ dose is a useful addition to our available metrics for tracking performance and compliance and supporting patient safety, furthering the goal of Total Quality Monitoring that our software provides.” Advanced models are used for organ dose simulations This agreement makes the Virtual Patient technology, a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques, available to Qaelum customers. It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, and pediatric patients from newborn through adolescence. The VirtualDoseCT calculation engine integrates seamlessly with the Qaelum software, providing improved information without extra effort on the part of the user. “We are thrilled to extend the use of our VirtualDose technology to Qaelum customers through this new partnership, and by doing this, improve patient safety in medical imaging worldwide” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc. A display screen from the QAELUM DOSE software An example output from VirtualDoseCT ABOUT QAELUM N.V. QAELUM is a high-tech spin-off company of the University Hospitals Leuven. Based on more than 15 years of quality assurance experience in an academic environment as well as in the field, QAELUM is considered as the preferred partner when it comes to medical imaging quality control. Leading hospital groups share our vision of a global system for quality assurance, which realizes optimal use of radiation and guarantees maximum safety for patients and staff. At the same time, they acquire a more detailed overview of and deeper insights into all quality related aspects. Passionate about solving real world problems, QAELUM focuses on the development and deployment of highly innovative solutions and services to resolve the daily problems of every medical imaging professional. Ranging from automated quality control in nationwide breast screening programs to optimized solutions for local patient dose monitoring, QAELUM has solutions for all these problems regardless of the scale. The combination of advanced software tools and expert knowledge in the field, makes the innovative solutions offering a preferred choice for healthcare professionals. Jurgen Jacobs PDG E-mail: jurgen.jacobs@qaelum.com Gsm: +32 472 801293 Sofie Ignoul Marketing...
read moreVirtual Phantoms at RSNA 2016
Virtual Phantoms Chief Technology Officer, Dr. Peter F. Caracappa, will be at the Radiological Society of North America annual meeting in Chicago, IL on November 29 & 30, 2016. If you would like to participate in a live demonstration of VirutalDoseCT, or discuss the VirtualDose system, contact peter.caracappa@virtualphantoms.com to schedule an appointment.
read moreNew VirtualDoseCT paper in Radiation Protection Dosimetry
A new evaluation of effective dose from CT scans using the VirutalDoseCT software has been released online prior to print publication by the Radiation Protection Dosimetry journal. PubMed abstract Publisher link to full text
read moreVirtual Phantoms Founder and CEO to present at AAPM
Dr. X. George Xu, founder and CEO of Virtual Phantoms, Inc., will be attending the annual meeting of the American Association of Physicists in Medicine in Washington, DC, on July 31-August 4. He will be presenting in a special session on Tuesday in Room 209. The abstract to his presentation, “Monte Carlo Assessment of Dose to the Lens of the Eye of Radiologist Using Realistic Phantoms and Eyeglass Models,” can be found here.
read moreFind Virtual Phantoms at RSNA 2015!
Virtual Phantoms Chief Technology Officer, Dr. Peter F. Caracappa, will be attending the Radiological Society of North America annual meeting, November 29-December 4 in Chicago, IL. If you would like to participate in a live demonstration of VirutalDoseCT, or discuss the VirtualDose system, contact peter.caracappa@virtualphantoms.com to schedule and appointment. See you in Chicago!
read moreVirtualDoseCT Reference Publication Released in Physics in Medicine and Biology
A new manuscript has recently been published in one of the leading medical physics journals in the world, providing a summary of the scientific basis behind the VirtualDoseCT system. The paper, “VirtualDose: a software for reporting organ doses from CT for adult and pediatric patients” appears in the 21 July issue if Physics in Medicine and Biology. Read the abstract via PubMed Access the full article (subscription required) at IOPScience The technology in VirtualDoseCT is backed by more than a decade of high-quality, peer-reviewed research. An up-to-date listing of the many papers and presentations related to VirtualDose and the Virtual Phantoms technology is always available at our papers page. ...
read morePACSHealth, LLC Unit Partners with Virtual Phantoms, Inc to Improve Patient Radiation Dose Monitoring
Scottsdale, AZ, July 10th , 2015 — PHS Technologies Group LLC, a division of PACSHealth, LLC, a developer of innovative software that records and analyzes ionizing radiation data from medical imaging procedures, announced today that it will integrate VirtualDose™CT software from Virtual Phantoms Inc. into their industry leading dose monitoring product DoseMonitor®. “We are pleased to announce the integration of a next generation tool into our popular DoseMonitor product. This feature will enhance organ dose modeling and ultimately improve patient safety during medical imaging procedures,” said Mike Battin, COO of PACSHealth, LLC. “The ability to effectively monitor radiation dose indices during certain medical imaging procedures has become increasingly important.” DoseMonitor is a single server, browser based software application that automates radiation dose data collection and reporting. It fully integrates into an RIS, EMR, and the American College of Radiology’s Dose Index Registry, helping to eliminate time-consuming manual steps and reducing input errors. Facilities can accurately depict historical exposure and compare, aggregate, and interpret data from ionizing radiation sources for an individual patient, exam, or between diagnostic modalities in multiple facilities. VirtualDose™CT is sophisticated radiation dose simulation software constructed with a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques that were developed from more than a decade of research. It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, and pediatric patients from newborn through adolescence. It includes data for the latest CT scanners and the most current risk coefficients for computation of effective dose. “We are thrilled to establish this new partnership with PHS Technologies Group to extend the VirtualDose technology to DoseMonitor customers,” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc. DoseMonitor’s capabilities include: Automated data collection for computed tomography (CT), mammography, direct radiography (DR), interventional radiography(XA), and cardiac angiography. Advanced report generation, including cumulative organ dose, dose by technologist by procedure, dose by physician by procedure, mammography reporting (organ and mean glandular dose), and age range support for alerts and notifications. Intelligent patient search—by name, partial name, medical record, and/or accession number. Compatibility with VMware®-based implementations, enabling hospitals to “virtualize” hardware on existing servers, reducing the need for new hardware and decreasing the total IT effort required to implement the solution. Support for direct data exchange with Nuance’s Powerscribe 360 | Reporting that places the dose index data directly into the interpretive report. About PHS Technologies Group LLC PHS Technologies Group, LLC is a division of PACSHealth, LLC, a medical software development company based in Scottsdale, AZ, which develops software systems for medical imaging technology. Their advanced applications help reduce patient exposure to ionizing radiation enabling hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines while increasing efficiency and reducing cost. For more information about DoseMonitor, please visit www.dosemonitor.com or call or email Mike Battin (877) 877-1457 x802; mike.battin@pacshealth.com. About VPI Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years research at RPI and UF in the field of nuclear and radiological...
read more